Back to BMY Stock Lookup

BMY – FDA

Mar 17, 2014 07:41 AM Five Prime Therapeutics (FPRX) Surges on Collaboration Agreement with Bristol-Myers Squibb (BMY)
Mar 14, 2014 01:04 PM Bristol-Myers (BMY), Pfizer (PFE) Report FDA Approval of Eliquis sNDA
Feb 24, 2014 08:35 AM Bristol-Myers Squibb (BMY) Investigational DCV Dual Regimen Receives Breakthrough Designation
Feb 3, 2014 06:22 AM AstraZeneca (AZN) Completes Acquisition of Bristol-Myers' (BMY) Diabetes Alliance Interests
Jan 24, 2014 08:17 AM Bristol-Myers Squibb (BMY) Tops Q4 EPS by 10c; Guides FY14 Profit Expectations
Jan 13, 2014 08:17 AM Portola Pharmaceuticals (PTLA) Enters Second Collaboration Deal with Bristol-Myers (BMY)
Jan 9, 2014 08:31 AM Vertex Pharma (VRTX) Issues Encouraging Update on VX-135 Phase 2a
Jan 8, 2014 11:49 AM FDA Approves Farxiga as Treatment for Type 2 Diabetes (BMY) (AZN)
Jan 8, 2014 07:21 AM Daclatasvir MAA for Hepatitis C Validated for Accelerated Regulatory Review by the EMA (BMY)
Dec 19, 2013 05:02 PM Bristol-Myers (BMY), Pfizer (PFE) sNDA for ELIQUIS Approved by FDA
Oct 28, 2013 07:45 AM Bristol-Myers Squibb (BMY) Issues Encouraging Update on Nivolumab in NSCLC
Oct 28, 2013 07:42 AM Bristol-Myers Squibb (BMY) Reports Clazakizumab Met Primary Endpoint in Phase IIb
Aug 13, 2013 03:23 PM Novartis (NVS), Pfizer (PFE) Out on Onyx (ONXX); Is Amgen (AMGN) the Sole Runner?
Aug 12, 2013 07:59 AM Regulators Probe Prescription of Antipsychotic Drugs for Children (BMY)
Jul 11, 2013 07:31 AM Bristol-Myers (BMY), Pfizer (PFE) Repor FDA Acceptance of Eliquis sNDA
Jul 1, 2013 04:22 PM Achillion (ACHN) Peers on Watch Following FDA Clinical Hold for Sovaprevir
Jun 20, 2013 02:11 PM Bristol-Myers (BMY), Otsuka Receive FDA Approval for Sprycel Label Update
Jun 19, 2013 06:20 AM Bristol-Myers (BMY), AstraZeneca (AZN) SAVOR-TIMI-53 Misses Primary Efficacy Endpoint in Phase 4
Jun 4, 2013 09:06 AM Bristol-Myers (BMY), AstraZeneca (AZN) Receive FDA Priority Review Designation for Metreleptin
Apr 23, 2013 08:35 AM Vertex Pharma (VRTX) Reports Significant Data from VX-135 in HCV RNA
Apr 22, 2013 07:39 AM Merck (MRK), Bristol-Myers Squib (BMY) Partner on Hepatitis C Combo
Apr 5, 2013 08:02 AM Vertex (VRTX) Enters non-Exclusive Pact with Bristol-Myers (BMY) for VX-135 Phase 2
Apr 1, 2013 11:47 AM Amarin's (AMRN) Vascepa Tracking Well 3-Months In; Investors Eye Tier 2 Designation
Mar 14, 2013 05:43 PM FDA to Review Certain Diabetes Drugs Over New Pancreas Concern (BMY) (LLY) (MRK)
Feb 8, 2013 10:11 AM Medicines Co (MDCO) Reports Recothrom License is Now Effective (BMY)
Jan 4, 2013 05:45 AM Tranzyme Pharma (TZYM) Completes Collaboration w/ Bristol-Myers (BMY)
Jan 2, 2013 08:03 AM ELIQUIS Receives FDA Approval in Reducing Certain Risks in Nonvalvular Atrial Fibrillation
Dec 28, 2012 04:14 PM Pfizer (PFE) and Bristol-Meyers (BMY) win FDA approval for Eliquis
Dec 26, 2012 07:30 AM Bristol-Myers (BMY), Pfizer (PFE) Receive Approval for ELIQUIS in Japan
Dec 12, 2012 07:02 AM The Medicines Co (MDCO) and Bristol-Myers Squibb (BMY) Enter Collaboration on Recothrom
Dec 3, 2012 01:45 PM Bristol-Myers (BMY) to terminate Avagacestat clinical developmen
Nov 20, 2012 01:55 PM Bristol-Myers (BMY), Pfizer (PFE) Receive EC Approval for ELIQUIS
Nov 14, 2012 11:55 AM Bristol-Myers (BMY), AstraZeneca (AZN) Receive EC Approval for Forxiga
Nov 12, 2012 03:31 PM Bristol-Myers (BMY) Says Peginterferon Achieved PDR in D-LITE Phase IIb
Nov 12, 2012 09:05 AM Bristol-Myers (BMY) Says Orencia Similar to Humira + MTX in PROs with RA
Oct 15, 2012 03:49 PM Bristol-Myers (BMY) Gets FDA Approval for Expanded BARACLUDE Indication
Oct 4, 2012 03:17 PM NACF Conference Could Create Catalyst for Vertex (VRTX) - Analyst
Oct 3, 2012 08:34 AM Sanofi (SNY) to Gain Back Plavix, Avapro/Avalide Rights, Pay Bristol-Myers (BMY) Royalty Fees
Sep 26, 2012 05:03 PM Bristol-Myers (BMY), Pfizer (PFE) Report FDA Acknowledgment of ELIQUIS NDA Resubmission
Sep 21, 2012 08:32 AM Vanderbilt, Bristol-Myers (BMY) Enter Parkinson’s Disease Treatment Development Collaboration
Aug 31, 2012 01:26 PM Akamai (AKAM) Wins Appeal in Content Delivery Patent Case vs. Limelight (LLNW)
Aug 28, 2012 03:42 PM Barclays on U.S. Biopharmaceuticals: Fate of Nucs Under Harsh Scrutiny - More Angst for IDIX; GILD Widens Lead
Aug 27, 2012 08:56 AM Idenix Pharma (IDIX) Peers on Watch as FDA Places Clinical Hold on Another HCV Treatment (ACHN) (GILD)
Aug 24, 2012 08:53 AM Bristol-Myers (BMY) Stock Drops 10% in Less than Month as Hepatitis C Drug Proves Dangerous
Aug 24, 2012 07:46 AM Bristol-Myers Squibb (BMY) to Take $1.8B Non-Cash Charge on Hep C Development Halt
Aug 24, 2012 06:45 AM Bristol-Myers (BMY) Discontinues Development of Hep C Treatment BMS-986094
Aug 17, 2012 02:54 PM Barclays Lowers Outlook on Idenix Pharmaceuticals (IDIX); Clarity on FDA Clinical Hold (BMY, VRTX, GILD)
Aug 17, 2012 08:46 AM Leerink Swann maintains an 'Outperform' on Idenix Pharmaceuticals (IDIX); Clinical Hold Feels More Like Precaution
Aug 15, 2012 08:01 AM Bristol-Myers Squibb (BMY), Otsuka America Launch Sprycel Patient Management Programs
Aug 9, 2012 07:46 AM Bristol-Myers (BMY), AstraZeneca (AZN) Make Initial $3.2B Payment to Amylin Pharma; AstraZeneca Exercises Rights Option

Back to BMY Stock Lookup